within Pharmacolibrary.Drugs.ATC.N;

model N02CD04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.41,
    Cl             = 87 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.35,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.009833333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ubrogepant is an orally administered, small molecule, calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the acute treatment of migraine with or without aura in adults. It is currently approved and used clinically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters obtained from healthy adult subjects, predominantly female, after single oral doses in the therapeutic range.</p><h4>References</h4><ol><li><p>Jakate, A, et al., &amp; Lipton, RB (2021). Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study. <i>Headache</i> 61(4) 642–652. DOI:<a href=&quot;https://doi.org/10.1111/head.14095&quot;>10.1111/head.14095</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33818780/&quot;>https://pubmed.ncbi.nlm.nih.gov/33818780</a></p></li><li><p>Boinpally, R, &amp; Lu, K (2022). Single-Dose Pharmacokinetics and Safety of Ubrogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 Trial. <i>Clinical pharmacology in drug development</i> 11(7) 857–864. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1066&quot;>10.1002/cpdd.1066</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35174666/&quot;>https://pubmed.ncbi.nlm.nih.gov/35174666</a></p></li><li><p>Boinpally, RR, et al., &amp; Trugman, JM (2025). Milk and plasma pharmacokinetics of single-dose ubrogepant in healthy lactating women. <i>Headache</i> None –. DOI:<a href=&quot;https://doi.org/10.1111/head.14960&quot;>10.1111/head.14960</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/40391560/&quot;>https://pubmed.ncbi.nlm.nih.gov/40391560</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02CD04;
